ProShares Ultra Nasdaq Biotechnology (BIB) Leverage/Terbalik
$109,80
▼ -0,67 (-0,61%)
Perubahan 1 hari
$62,04 – $126,40
Rentang 52 minggu
Data kepemilikan belum tersedia untuk dana ini.
BIB Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Performa per 2 Okt. 2026
| Periode | Imbal hasil harga | Imbal hasil total |
|---|---|---|
| 1M | ▼ -9,84% | ▼ -9,78% |
| 3M | ▲ +2,77% | ▲ +2,84% |
| 6M | ▲ +34,28% | ▲ +34,37% |
| YTD | ▲ +37,63% | ▲ +37,74% |
| 1Y | ▲ +73,21% | ▲ +73,64% |
| 3Y | ▲ +135,47% | ▲ +142,03% |
| 5Y | ▲ +20,16% | ▲ +23,54% |
| Maks | ▲ +1362,31% | ▲ +1406,10% |
Volatilitas 1T42,75%
Volatilitas 3Y41,86%
Penurunan Maksimum 3Y
-45,99%
Beta 3Y0,85
Sharpe 1Y*1,50
Total pengembalian mengasumsikan dividen diinvestasikan kembali. Pengembalian tidak dibandingkan dengan indeks. * Rasio Sharpe dihitung dengan suku bunga bebas risiko 0%.
Aliran dana (dilaporkan SEC)
Bulan lalu (Mei 2026)
-$4.8M
Kuartal berakhir Mei 2026
-$13.9M
12 bulan terakhir
-$12.0M
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Komposisi Penuh 267 saham
| Nama | CUSIP | Nilai | % | Saldo | Kategori | Negara |
|---|---|---|---|---|---|---|
| Legend Biotech Corp. | 52490G102 | $85K | 0,12 | 3.122 | EC | KY |
| Kodiak Sciences, Inc. | 50015M109 | $83K | 0,11 | 2.255 | EC | US |
| BioCryst Pharmaceuticals, Inc. | 09058V103 | $83K | 0,11 | 9.271 | EC | US |
| Kiniksa Pharmaceuticals International plc | · | $82K | 0,11 | 1.698 | EC | GB |
| Aurinia Pharmaceuticals, Inc. | 05156V102 | $75K | 0,10 | 4.914 | EC | CA |
| Ocular Therapeutix, Inc. | 67576A100 | $73K | 0,10 | 8.049 | EC | US |
| Novocure Ltd. | · | $72K | 0,10 | 4.209 | EC | JE |
| Pharvaris NV | · | $71K | 0,10 | 2.367 | EC | NL |
| Sionna Therapeutics, Inc. | 829401108 | $71K | 0,10 | 1.651 | EC | US |
| ADMA Biologics, Inc. | 000899104 | $70K | 0,10 | 8.805 | EC | US |
| Rapport Therapeutics, Inc. | 75383L102 | $70K | 0,09 | 1.764 | EC | US |
| Zymeworks, Inc. | 98985Y108 | $70K | 0,09 | 2.766 | EC | US |
| Recursion Pharmaceuticals, Inc. | 75629V104 | $69K | 0,09 | 19.297 | EC | US |
| Sarepta Therapeutics, Inc. | 803607100 | $69K | 0,09 | 3.875 | EC | US |
| AbCellera Biologics, Inc. | 00288U106 | $69K | 0,09 | 11.209 | EC | CA |
| Harmony Biosciences Holdings, Inc. | 413197104 | $68K | 0,09 | 2.140 | EC | US |
| Nurix Therapeutics, Inc. | 67080M103 | $68K | 0,09 | 3.802 | EC | US |
| Trevi Therapeutics, Inc. | 89532M101 | $67K | 0,09 | 4.742 | EC | US |
| Novavax, Inc. | 670002401 | $66K | 0,09 | 6.023 | EC | US |
| Tyra Biosciences, Inc. | 90240B106 | $66K | 0,09 | 1.974 | EC | US |
| uniQure NV | · | $66K | 0,09 | 2.305 | EC | NL |
| Stoke Therapeutics, Inc. | 86150R107 | $65K | 0,09 | 2.111 | EC | US |
| ANI Pharmaceuticals, Inc. | 00182C103 | $65K | 0,09 | 830 | EC | US |
| Syndax Pharmaceuticals, Inc. | 87164F105 | $64K | 0,09 | 3.261 | EC | US |
| Agios Pharmaceuticals, Inc. | 00847X104 | $64K | 0,09 | 2.166 | EC | US |
| Genmab A/S | 372303206 | $63K | 0,09 | 2.379 | EC | DK |
| Vericel Corp. | 92346J108 | $62K | 0,08 | 1.875 | EC | US |
| Iovance Biotherapeutics, Inc. | 462260100 | $62K | 0,08 | 15.232 | EC | US |
| Intellia Therapeutics, Inc. | 45826J105 | $61K | 0,08 | 4.369 | EC | US |
| AtaiBeckley, Inc. | 04650F101 | $61K | 0,08 | 13.429 | EC | US |
| Taysha Gene Therapies, Inc. | 877619106 | $59K | 0,08 | 10.128 | EC | US |
| Innoviva, Inc. | 45781M101 | $59K | 0,08 | 2.740 | EC | US |
| Amylyx Pharmaceuticals, Inc. | 03237H101 | $58K | 0,08 | 4.059 | EC | US |
| AnaptysBio, Inc. | 032724106 | $57K | 0,08 | 1.023 | EC | US |
| Precigen, Inc. | 74017N105 | $57K | 0,08 | 13.080 | EC | US |
| Inhibrx Biosciences, Inc. | 45720N103 | $56K | 0,08 | 537 | EC | US |
| Monte Rosa Therapeutics, Inc. | 61225M102 | $56K | 0,08 | 2.818 | EC | US |
| Vir Biotechnology, Inc. | 92764N102 | $55K | 0,08 | 5.810 | EC | US |
| GH Research plc | · | $55K | 0,07 | 2.294 | EC | IE |
| Ardelyx, Inc. | 039697107 | $55K | 0,07 | 9.066 | EC | US |
| Fortrea Holdings, Inc. | 34965K107 | $53K | 0,07 | 3.455 | EC | US |
| MBX Biosciences, Inc. | 55287L101 | $52K | 0,07 | 1.658 | EC | US |
| Bicara Therapeutics, Inc. | 055477103 | $51K | 0,07 | 2.343 | EC | US |
| KalVista Pharmaceuticals, Inc. | 483497103 | $50K | 0,07 | 1.870 | EC | US |
| Septerna, Inc. | 81734D104 | $50K | 0,07 | 1.657 | EC | US |
| UroGen Pharma Ltd. | · | $49K | 0,07 | 1.730 | EC | IL |
| Harrow, Inc. | 415858109 | $48K | 0,07 | 1.370 | EC | US |
| Maze Therapeutics, Inc. | 578784100 | $47K | 0,06 | 1.778 | EC | US |
| Immunocore Holdings plc | 45258D105 | $47K | 0,06 | 1.621 | EC | GB |
| ArriVent Biopharma, Inc. | 04272N102 | $46K | 0,06 | 1.527 | EC | US |
Dividen 13 pembayaran
0,20%Imbal hasil TTM
$0,23Pembayaran TTM / saham
Kuartalan
(est.)
| Tanggal ex-dividen | Jumlah / saham |
|---|---|
| 23 Sep. 2026 | $0,0830 |
| 25 Maret 2026 | $0,0070 |
| 24 Des. 2025 | $0,1350 |
| 24 Sep. 2025 | $0,1810 |
| 25 Juni 2025 | $0,1710 |
| 26 Maret 2025 | $0,1310 |
| 23 Des. 2024 | $0,3960 |
| 25 Sep. 2024 | $0,1530 |
| 26 Juni 2024 | $0,2650 |
| 20 Maret 2024 | $0,0400 |
| 20 Des. 2023 | $0,0380 |
| 22 Des. 2022 | $0,0200 |
| 21 Sep. 2010 | $0,0110 |
Pemilik institusional (13F) 22 pengaju
Institusi yang melaporkan kepemilikan ETF ini dalam Formulir SEC 13F triwulanan mereka. Hanya posisi long; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Institusi | Nilai | % dari 13F yang dilacak | Saham | Tipe | Per tanggal |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $785.973 | 21,94% | 7.802 | Saham | 30 Juni 2026 |
| Capital Investment Advisors, LLC | $599.013 | 16,72% | 5.946 | Saham | 30 Juni 2026 |
| Kaizen Financial Strategies | $535.554 | 14,95% | 5.315 | Saham | 30 Juni 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $413.034 | 11,53% | 4.100 | Opsi beli | 30 Juni 2026 |
| Palumbo Wealth Management LLC | $402.960 | 11,25% | 4.000 | Saham | 30 Juni 2026 |
| CITADEL ADVISORS LLC | $302.220 | 8,44% | 3.000 | Opsi beli | 30 Juni 2026 |
| Jump Financial, LLC | $257.189 | 7,18% | 2.553 | Saham | 30 Juni 2026 |
| TOTH FINANCIAL ADVISORY CORP | $102.957 | 2,87% | 1.022 | Saham | 30 Juni 2026 |
| FRANKLIN RESOURCES INC | $70.115 | 1,96% | 696 | Saham | 30 Juni 2026 |
| PNC Financial Services Group, Inc. | $50.370 | 1,41% | 500 | Saham | 30 Juni 2026 |
| Ashton Thomas Private Wealth, LLC | $37.576 | 1,05% | 373 | Saham | 30 Juni 2026 |
| Truvestments Capital LLC | $12.593 | 0,35% | 125 | Saham | 30 Juni 2026 |
| Axiom Investment Management LLC | $5.037 | 0,14% | 50 | Saham | 30 Juni 2026 |
| Qube Research & Technologies Ltd | $4.936 | 0,14% | 49 | Saham | 30 Juni 2026 |
| SIMPLEX TRADING, LLC | $1.309 | 0,04% | 13 | Saham | 30 Juni 2026 |
| CHASE INVESTMENT COUNSEL CORP | $241 | 0,01% | 2.400 | Saham | 30 Juni 2026 |
| Rockefeller Capital Management L.P. | $201 | 0,01% | 2 | Saham | 30 Juni 2026 |
| MORGAN STANLEY | $131 | 0,00% | 1 | Saham | 30 Juni 2026 |
| UBS Group AG | $101 | 0,00% | 1 | Saham | 30 Juni 2026 |
| WELLS FARGO & COMPANY/MN | $65 | 0,00% | 1 | Saham | 30 Juni 2026 |
| Harel Insurance Investments & Financial Services Ltd. | $20 | 0,00% | 198 | Saham | 30 Juni 2026 |
| ROYAL BANK OF CANADA | $0 | 0,00% | 1 | Saham | 30 Juni 2026 |